Barclays, JP Morgan among banks facing UK class action over forex-rigging

Traders work on the trading floor of Barclays bank at Canary Wharf in London. Barclays is one of several major investment banks facing allegations of forex rigging. (Reuters)
Updated 29 July 2019
Follow

Barclays, JP Morgan among banks facing UK class action over forex-rigging

  • Some of the world’s biggest investment banks have already paid more than a combined $11 billion in fines to settle US, British and European regulatory allegations that traders rigged the currency markets

LONDON: Barclays, JP Morgan , RBS, UBS and Citigroup are being sued by investors over allegations they rigged the global foreign exchange market, in a test of US-style class actions in Britain.
The claim, estimated to be worth more than 1 billion pounds ($1.24 billion), was filed at the Competition Appeal Tribunal (CAT) on Monday, US law firm Scott + Scott said.
JP Morgan, RBS, UBS, Barclays and Citi declined to comment.
Some of the world’s biggest investment banks have already paid more than a combined $11 billion in fines to settle US, British and European regulatory allegations that traders rigged the currency markets.
Litigators have long hoped to replicate in Britain the success of US class action claims against banks, including Goldman Sachs, HSBC and Barclays, that have resulted $2.3 billion in settlements for big investors.
In May the European Union fined five banks a combined 1.07 billion euros ($1.19 billion) for forex rigging through cartels of traders known as “Essex Express” and “Three Way Banana Split.”
The lawsuit is being led by Michael O’Higgins, the former chairman of British watchdog the Pensions Regulator, and is being funded by litigation finance group Therium.
O’Higgins told Reuters the total value of the claim would depend on the number of forex trades executed in London for UK-domiciled units — which will be automatically included in the action — and the proportional impact of rate rigging on these.
Given the size of London’s forex market, O’Higgins said the total value would likely exceed a billion pounds.
“Even on a relatively conservative assumption it’s certainly a billion pounds and possibly several,” O’Higgins said.
“Markets should be fair as well as free and in this case the markets weren’t fair.”

Class action test
The “massive” action is a “perfect” case to be brought as a so-called opt-out collective class action for breaches of UK or European Union competition law, David Scott told Reuters.
“It is a very difficult case to put together individual damages which are significant enough,” the Scott + Scott lawyer added.
Britain’s Consumer Rights Act (CRA) in 2015 introduced “opt-out” class actions for breaches of British or EU competition law. In such cases, UK-based members of a defined group will automatically be bound into a legal action unless they opt out, saving on hefty advertising costs. Overseas-based claimants, however, will still have to actively sign up.
The regime is designed to offer a more effective route to compensation for consumers and businesses who fall victim to anti-competitive conduct and is overseen by the CAT.
Its first major test case — a 14 billion pound claim against Mastercard for allegedly overcharging more than 45 million people in Britain over a 16-year period — was blocked by the CAT in 2017, a decision that was overturned at the Court of Appeal and is set to be heard by the Supreme Court.
This wrangling has already delayed other class actions and some law firms have chosen a different legal route for offering pension funds, asset managers and other institutional investors the chance to hold banks to account.
Law firm Quinn Emanuel Urquhart & Sullivan in December filed a damages claim against six banks through London’s commercial courts, which it said has already signed up some of the biggest institutional investors.


Saudi-French cooperation to localize veterinary vaccine manufacturing

Updated 17 February 2026
Follow

Saudi-French cooperation to localize veterinary vaccine manufacturing

RIYADH: In the presence of sector leaders, the National Livestock and Fisheries Development Program signed a memorandum of understanding with French company Ceva under the patronage of Minister of Environment, Water and Agriculture Abdulrahman bin Abdulmohsen Al-Fadhli, who also chairs the program’s board.

The agreement aims to localize vaccine manufacturing, transfer technology and technical expertise, and expand the industrial and commercial production of veterinary vaccines across the Kingdom.

According to the MoU, the two parties will work to achieve high efficiency in mass production scale-up and establish a clear path for sustainable commercial operation that meets the needs of the local and national market, as well as strengthen the biosecurity and food security system.

The MoU also includes the development and modernization of messenger RNA vaccine technologies, along with joint research and development of a Middle East Respiratory Syndrome vaccine for camels. This involves designing, evaluating, and developing vaccines specifically tailored to combat the virus.

The agreement also covers the development of a rabies vaccine and related solutions, as well as supporting national efforts to control the disease through vaccine provision, capacity building, and the implementation of integrated prevention strategies.

The collaboration between the program and Ceva aims to meet the needs of the poultry vaccine market in the Kingdom, currently estimated at around SR750 million ($199 million).

The company will work to cover approximately 30 percent of this market with an initial investment of around SR250 million.

With continued government support for poultry projects and increased production in the sector, the market is expected to grow at a rate exceeding 10 percent annually, reaching approximately SR1.25 billion by 2030.

The addition of the world’s leading poultry vaccine manufacturer to Biotech Park highlights the program’s key role in developing new industries within the livestock and fisheries sector.

It also highlights the program’s commitment to building international partnerships with global companies, organizations, research centers, and universities to support advanced biotechnology industries and attract high-quality investments. It also seeks to create new economic sectors based on biotechnology, enhance veterinary health security, and support the sustainable economic development of the livestock sector, as well as empower national and emerging companies and provide advanced research and industrial infrastructure.

This will solidify the Kingdom’s position as a global hub for biotechnology industries and the development of national capabilities.

Ceva is the first international partner to join Biotech Park, the future veterinary biotechnology city launched by the program in Dhurma Governorate. The city is the world’s first specialized and fully integrated hub for veterinary biotechnology, serving as a benchmark for sector development and a platform supporting markets across the Kingdom, the Gulf, the Middle East, Africa and beyond.

The signing of Ceva is a significant step, given its position as the world’s leading manufacturer of poultry vaccines and medicines, and one of the most prominent international companies in the field of biotechnology.

The MoU aims to localize the veterinary vaccine industry, ensuring its compatibility with the strains of poultry diseases prevalent in Saudi Arabia. This includes the transfer of technology and technical expertise from Ceva, along with the implementation of specialized training programs to guarantee that manufacturing facilities comply with international Good Manufacturing Practice standards.